ID

16867

Description

Study Sponsor: Astellas Study Title Tolerability of QUTENZA™ When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study Medicine or Vaccine (generic name) capsaicin Sponsor Identification Number QTZ-EC-0002 Trial Registry Identification Number(#'s) NCT01416116 EudraCT Number: 2010-023258-34 Medical Condition Neuropathic pain Phase Phase 4 http://clinicaltrials.gov/show/NCT01416116 Treatment Visit Form 2/5: Randomization Vital Signs: 75 mins prior to patch application Vital Signs: 15 mins prior to patch application Post patch application and post patch removal

Lien

http://clinicaltrials.gov/show/NCT01416116

Mots-clés

  1. 24/07/2016 24/07/2016 -
  2. 11/08/2016 11/08/2016 -
Téléchargé le

11 août 2016

DOI

Pour une demande vous connecter.

Licence

Creative Commons BY 4.0

Modèle Commentaires :

Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.

Groupe Item commentaires pour :

Item commentaires pour :

Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.

Treatment Visit Form 2/5 Tolerability of QUTENZA™ When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study NCT01416116

Treatment Visit Form 2/5 Tolerability of QUTENZA™ When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study NCT01416116

Randomization
Description

Randomization

Date of Randomization
Description

Date of Randomization

Type de données

date

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0011008
Randomization Number
Description

Randomization Number

Type de données

integer

Alias
UMLS CUI [1,1]
C0030705
UMLS CUI [1,2]
C0600091
UMLS CUI [1,3]
C0034656
Dose/Group
Description

Dose/Group

Type de données

integer

Alias
UMLS CUI [1,1]
C3174092
UMLS CUI [1,2]
C0034656
UMLS CUI [1,3]
C0441833
Vital Signs: 75 mins prior to patch application
Description

Vital Signs: 75 mins prior to patch application

Assessment Date
Description

Assessment Date

Type de données

date

Alias
UMLS CUI [1]
C2985720
Scheduled Time
Description

Scheduled Time

Type de données

time

Alias
UMLS CUI [1]
C0086960
Assessment Time
Description

Assessment Time

Type de données

time

Alias
UMLS CUI [1,1]
C0518766
UMLS CUI [1,2]
C0040223
Position
Description

Position

Type de données

integer

Alias
UMLS CUI [1]
C0733755
Systolic Blood Pressure
Description

For any AE, please provide details on the 'Adverse Event' form.

Type de données

text

Unités de mesure
  • mmHg
Alias
UMLS CUI [1]
C0871470
mmHg
Diastolic Blood Pressure
Description

Diastolic Blood Pressure

Type de données

text

Unités de mesure
  • mmHg
Alias
UMLS CUI [1]
C0428883
mmHg
Pulse Rate
Description

Record any clinically significant abnormal findings/conditions identified during the exam on the Current Medical and Surgical History and/or Adverse Event form.

Type de données

integer

Alias
UMLS CUI [1]
C0232117
Vital Signs: 15 mins prior to patch application
Description

Vital Signs: 15 mins prior to patch application

Assessment Date
Description

Assessment Date

Type de données

date

Alias
UMLS CUI [1]
C2985720
Scheduled Time
Description

Scheduled Time

Type de données

time

Alias
UMLS CUI [1]
C0086960
Assessment Time
Description

Assessment Time

Type de données

time

Alias
UMLS CUI [1,1]
C0518766
UMLS CUI [1,2]
C0040223
Position
Description

Position

Type de données

integer

Alias
UMLS CUI [1]
C0733755
Systolic Blood Pressure
Description

For any AE, please provide details on the 'Adverse Event' form.

Type de données

text

Unités de mesure
  • mmHg
Alias
UMLS CUI [1]
C0871470
mmHg
Diastolic Blood Pressure
Description

Diastolic Blood Pressure

Type de données

text

Unités de mesure
  • mmHg
Alias
UMLS CUI [1]
C0428883
mmHg
Pulse Rate
Description

Record any clinically significant abnormal findings/conditions identified during the exam on the Current Medical and Surgical History and/or Adverse Event form.

Type de données

integer

Alias
UMLS CUI [1]
C0232117
Vital Signs: Post patch application and post patch rGeemnoevraatl
Description

Vital Signs: Post patch application and post patch rGeemnoevraatl

Assessment Date
Description

Assessment Date

Type de données

date

Alias
UMLS CUI [1]
C2985720
Scheduled Time
Description

Scheduled Time

Type de données

time

Alias
UMLS CUI [1]
C0086960
Assessment Time
Description

Assessment Time

Type de données

time

Alias
UMLS CUI [1,1]
C0518766
UMLS CUI [1,2]
C0040223
Position
Description

Position

Type de données

integer

Alias
UMLS CUI [1]
C0733755
Systolic Blood Pressure
Description

For any AE, please provide details on the 'Adverse Event' form.

Type de données

text

Unités de mesure
  • mmHg
Alias
UMLS CUI [1]
C0871470
mmHg
Diastolic Blood Pressure
Description

Diastolic Blood Pressure

Type de données

text

Unités de mesure
  • mmHg
Alias
UMLS CUI [1]
C0428883
mmHg
Pulse Rate
Description

Record any clinically significant abnormal findings/conditions identified during the exam on the Current Medical and Surgical History and/or Adverse Event form.

Type de données

integer

Alias
UMLS CUI [1]
C0232117

Similar models

Treatment Visit Form 2/5 Tolerability of QUTENZA™ When Applied After Pre-treatment With Lidocaine or Tramadol in Subjects With Peripheral Neuropathic Pain - A Randomized, Multi-center, Assessor-blinded Study NCT01416116

Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Item Group
Randomization
Date of Randomization
Item
Date of Randomization
date
C0034656 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Randomization Number
Item
Randomization Number
integer
C0030705 (UMLS CUI [1,1])
C0600091 (UMLS CUI [1,2])
C0034656 (UMLS CUI [1,3])
Item
Dose/Group
integer
C3174092 (UMLS CUI [1,1])
C0034656 (UMLS CUI [1,2])
C0441833 (UMLS CUI [1,3])
Code List
Dose/Group
CL Item
Arm 1: Lidocaine 4% (1)
CL Item
Arm 2: Tramadol (2)
Item Group
Vital Signs: 75 mins prior to patch application
Assessment Date
Item
Assessment Date
date
C2985720 (UMLS CUI [1])
Scheduled Time
Item
Scheduled Time
time
C0086960 (UMLS CUI [1])
Assessment Time
Item
Assessment Time
time
C0518766 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Item
Position
integer
C0733755 (UMLS CUI [1])
Code List
Position
CL Item
Supine (1 )
CL Item
Sitting (2 )
CL Item
Standing (3 )
Systolic Blood Pressure
Item
Systolic Blood Pressure
text
C0871470 (UMLS CUI [1])
Diastolic Blood Pressure
Item
Diastolic Blood Pressure
text
C0428883 (UMLS CUI [1])
Pulse Rate
Item
Pulse Rate
integer
C0232117 (UMLS CUI [1])
Item Group
Vital Signs: 15 mins prior to patch application
Assessment Date
Item
Assessment Date
date
C2985720 (UMLS CUI [1])
Scheduled Time
Item
Scheduled Time
time
C0086960 (UMLS CUI [1])
Assessment Time
Item
Assessment Time
time
C0518766 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Item
Position
integer
C0733755 (UMLS CUI [1])
Code List
Position
CL Item
Supine (1 )
CL Item
Sitting (2 )
CL Item
Standing (3 )
Systolic Blood Pressure
Item
Systolic Blood Pressure
text
C0871470 (UMLS CUI [1])
Diastolic Blood Pressure
Item
Diastolic Blood Pressure
text
C0428883 (UMLS CUI [1])
Pulse Rate
Item
Pulse Rate
integer
C0232117 (UMLS CUI [1])
Item Group
Vital Signs: Post patch application and post patch rGeemnoevraatl
Assessment Date
Item
Assessment Date
date
C2985720 (UMLS CUI [1])
Scheduled Time
Item
Scheduled Time
time
C0086960 (UMLS CUI [1])
Assessment Time
Item
Assessment Time
time
C0518766 (UMLS CUI [1,1])
C0040223 (UMLS CUI [1,2])
Item
Position
integer
C0733755 (UMLS CUI [1])
Code List
Position
CL Item
Supine (1 )
CL Item
Sitting (2 )
CL Item
Standing (3 )
Systolic Blood Pressure
Item
Systolic Blood Pressure
text
C0871470 (UMLS CUI [1])
Diastolic Blood Pressure
Item
Diastolic Blood Pressure
text
C0428883 (UMLS CUI [1])
Pulse Rate
Item
Pulse Rate
integer
C0232117 (UMLS CUI [1])

Utilisez ce formulaire pour les retours, les questions et les améliorations suggérées.

Les champs marqués d’un * sont obligatoires.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial